Yudong Qiu Selected Research

Yudong Qiu Research Topics

Disease

27	Neoplasms (Cancer) 02/2024 - 01/2007
12	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 02/2017
10	Hepatocellular Carcinoma (Hepatoma) 02/2022 - 01/2007
7	Cholangiocarcinoma 10/2023 - 05/2012
5	Infections 09/2023 - 08/2015
4	Pancreatic Fistula (Pancreatic Fistulas) 09/2023 - 01/2021
4	Carcinoma (Carcinomatosis) 05/2023 - 01/2013
2	Surgical Wound Infection 02/2024 - 01/2021
2	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2020
2	Liver Neoplasms (Liver Cancer) 01/2021 - 05/2013
2	Hemorrhage 01/2021 - 10/2012
2	Liver Cirrhosis (Hepatic Cirrhosis) 12/2020 - 11/2017
2	Klatskin Tumor 04/2020 - 08/2019
1	Tertiary Lymphoid Structures 12/2023
1	Adenocarcinoma 11/2023
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 11/2023
1	Inflammation (Inflammations) 11/2023
1	Pancreatitis 09/2023
1	Lymphoma (Lymphomas) 07/2023
1	Intraabdominal Infections 05/2023
1	Obstructive Jaundice (Cholestatic Jaundice) 05/2023
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 04/2023
1	Postoperative Pain 12/2022
1	Pathologic Complete Response 01/2022
1	Circulating Neoplastic Cells 01/2022
1	Genetic Translocation (Chromosomal Translocation) 11/2021
1	Flatulence 01/2021
1	Pancreatic Diseases (Pancreatic Disease) 09/2020
1	Calculi (Calculus) 02/2019
1	Abdominal Pain (Pain, Abdominal) 02/2019
1	Carcinogenesis 01/2019
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2019
1	Fatty Liver 11/2017
1	Dyslipidemias (Dyslipidemia) 11/2017
1	Non-alcoholic Fatty Liver Disease 11/2017
1	Chronic Hepatitis (Chronic Active Hepatitis) 11/2017

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2019
5	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2021
3	BilirubinIBA 05/2023 - 10/2012
3	Messenger RNA (mRNA)IBA 01/2022 - 11/2017
3	Gemcitabine FDA Link 01/2022 - 12/2020
2	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2022
2	C-Reactive ProteinIBA 04/2023 - 09/2022
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022 - 09/2020
2	130-nm albumin-bound paclitaxelIBA 01/2022 - 01/2022
2	Circulating Tumor DNAIBA 01/2022 - 01/2022
2	LigandsIBA 01/2022 - 09/2020
2	CateninsIBA 05/2021 - 12/2020
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 05/2021 - 12/2020
2	cyanoginosin LR (microcystin LR)IBA 02/2021 - 12/2020
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021 - 01/2018
2	Capsules (Microcapsules)IBA 03/2017 - 07/2007
2	AlbuminsIBA 10/2015 - 10/2012
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 02/2024
1	Claudin-1IBA 02/2024
1	Indicators and Reagents (Reagents)IBA 12/2023
1	CarbonIBA 11/2023
1	Vitamin B 6IBA 11/2023
1	MicronutrientsIBA 11/2023
1	CopperIBA 10/2023
1	LipidsIBA 10/2023
1	celastrolIBA 10/2023
1	N- (3- phenyl- n- propyl)- 1- phenyl- 2- aminopropane (PPAP)IBA 09/2023
1	Interleukin-6 (Interleukin 6)IBA 04/2023
1	Analgesics (Analgesic Drugs)IBA 12/2022
1	Alkaline PhosphataseIBA 09/2022
1	gadolinium ethoxybenzyl DTPA FDA Link 02/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	tislelizumabIBA 01/2022
1	Polo-Like Kinase 1IBA 01/2022
1	RO3280IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Phosphotransferases (Kinase)IBA 11/2021
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 11/2021
1	Transcription Factors (Transcription Factor)IBA 12/2020
1	ParaffinIBA 11/2020
1	Formaldehyde (Formol)FDA Link 11/2020
1	CholesterolIBA 04/2020
1	AntigensIBA 02/2019
1	Carcinoembryonic AntigenIBA 02/2019
1	CarbohydratesIBA 02/2019
1	NivolumabIBA 01/2019
1	GlypicansIBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2017
1	Zoledronic Acid (Zometa)FDA Link 11/2017

Therapy/Procedure

8	Hepatectomy 01/2021 - 08/2015
7	Therapeutics 11/2023 - 11/2017
6	Drug Therapy (Chemotherapy) 10/2023 - 01/2022
5	Pancreaticoduodenectomy 02/2024 - 12/2021
5	Liver Transplantation 04/2016 - 01/2003
3	Length of Stay 09/2023 - 12/2022
3	Radiotherapy 01/2022 - 01/2019
2	Pancreatectomy 09/2023 - 01/2021
2	Enteral Nutrition (Feeding, Tube) 01/2021 - 11/2015
2	Radiofrequency Ablation 04/2016 - 11/2014
1	Antibiotic Prophylaxis 02/2024
1	Chemoradiotherapy 01/2023
1	Immunotherapy 01/2022
1	Neoadjuvant Therapy 01/2022
1	Lymph Node Excision (Lymph Node Dissection) 08/2019